CSC
PMD

Caldwell Sutter Capital’s Psychemedics Corporation PMD Stock Holding History

Caldwell Sutter Capital’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,250
Closed -$45.4K – 922
2024
Q4 		$45.4K Buy
20,250
+20,000
+8,000% +$47.4K 0.02% 371
2024
Q3 		$578 Hold
250
– – ﹤0.01% 847
2024
Q2 		$605 Buy
250
+220
+733% +$559 ﹤0.01% 853
2024
Q1 		$88 Hold
30
– – ﹤0.01% 897
2023
Q4 		$89 Hold
30
– – ﹤0.01% 931
2023
Q3 		$119 Sell
30
-547
-95% -$2.44K ﹤0.01% 862
2023
Q2 		$2.63K Buy
+577
New +$2.92K ﹤0.01% 699

Other funds holding PMD

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return

Caldwell Sutter Capital's PMD Position: Q1 2025 in Review

Caldwell Sutter Capital sold out of Psychemedics Corporation (PMD) in Q1 2025, closing a stake of 20,250 shares — an estimated $45.4K sold.

Caldwell Sutter Capital first reported a position in PMD in Q2 2023 and held it in 7 quarters. The position peaked at $45.4K in Q4 2024. 1 fund tracked by Wall St. Rank holds PMD as of Q1 2025.

  • Caldwell Sutter Capital reported no remaining Psychemedics Corporation position as of Q1 2025 after selling out during the quarter.
  • Caldwell Sutter Capital sold 20,250 Psychemedics Corporation shares in Q1 2025, an estimated $45.4K.
  • Caldwell Sutter Capital first reported a position in Psychemedics Corporation in Q2 2023 and held it in 7 quarters.
  • Caldwell Sutter Capital's Psychemedics Corporation position peaked at $45.4K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2025.

Based on Caldwell Sutter Capital's 13F filing for Q1 2025, filed 16 Apr 2025.